Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Pujol

Showing results (121-130 of 155) with videos related to

Pageof 16
Sort By:
The Oncologist|February 22, 2001
Long term analysis of survival in the European randomized trial comparing vinorelbine/cisplatin to vindesine/cisplatin and vinorelbine alone in advanced non-small cell lung cancerT Le Chevalier, D Brisgand, J C Soria, et al.
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|January 1, 1991
Unexplained CD4-positive T-cell deficiency in non-HIV patients presenting as a Pneumocystis carinii pneumoniaV Gautier, P Chanez, J P Vendrell, et al.
Cancer|June 20, 2001
Patterns of relapse of N2 nonsmall-cell lung carcinoma patients treated with preoperative chemotherapy: should prophylactic cranial irradiation be reconsidered?F Andre, D Grunenwald, J L Pujol, et al.
Bulletin Du Cancer|January 1, 1989
[Results of a phase II study of the combination of cis-platinum and 5-FU in epidermoid or undifferentiated large cell bronchial cancer]A Rivière, D Abouz, P Ayela, et al.
The European Respiratory Journal|January 1, 1996
Comparison of an expert system with other clinical scores for the evaluation of severity of asthmaV Gautier, H Rédier, J L Pujol, et al.
British Journal of Cancer|June 1, 1993
Clinical evaluation of serum tumour marker CA 242 in non-small cell lung cancerJ L Pujol, E H Cooper, M Lehmann, et al.
British Journal of Cancer|April 5, 2001
Brain metastases at the time of presentation of non-small cell lung cancer: a multi-centric AERIO analysis of prognostic factorsW Jacot, X Quantin, J M Boher, et al.
Seminars in Oncology|October 1, 1994
A three-arm trial of vinorelbine (Navelbine) plus cisplatin, vindesine plus cisplatin, and single-agent vinorelbine in the treatment of non-small cell lung cancer: an expanded analysisT Le Chevalier, J L Pujol, J Y Douillard, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 1994
Randomized study of vinorelbine and cisplatin versus vindesine and cisplatin versus vinorelbine alone in advanced non-small-cell lung cancer: results of a European multicenter trial including 612 patientsT Le Chevalier, D Brisgand, J Y Douillard, et al.
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|November 1, 1989
Substance P activation of bronchoalveolar macrophages from asthmatic patients and normal subjectsJ L Pujol, J Bousquet, J Grenier, et al.
Pageof 16

Showing results (121-130 of 155) with videos related to

Sort By:
Pageof 16
The Oncologist|February 22, 2001
Long term analysis of survival in the European randomized trial comparing vinorelbine/cisplatin to vindesine/cisplatin and vinorelbine alone in advanced non-small cell lung cancerT Le Chevalier, D Brisgand, J C Soria, et al.
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|January 1, 1991
Unexplained CD4-positive T-cell deficiency in non-HIV patients presenting as a Pneumocystis carinii pneumoniaV Gautier, P Chanez, J P Vendrell, et al.
Cancer|June 20, 2001
Patterns of relapse of N2 nonsmall-cell lung carcinoma patients treated with preoperative chemotherapy: should prophylactic cranial irradiation be reconsidered?F Andre, D Grunenwald, J L Pujol, et al.
Bulletin Du Cancer|January 1, 1989
[Results of a phase II study of the combination of cis-platinum and 5-FU in epidermoid or undifferentiated large cell bronchial cancer]A Rivière, D Abouz, P Ayela, et al.
The European Respiratory Journal|January 1, 1996
Comparison of an expert system with other clinical scores for the evaluation of severity of asthmaV Gautier, H Rédier, J L Pujol, et al.
British Journal of Cancer|June 1, 1993
Clinical evaluation of serum tumour marker CA 242 in non-small cell lung cancerJ L Pujol, E H Cooper, M Lehmann, et al.
British Journal of Cancer|April 5, 2001
Brain metastases at the time of presentation of non-small cell lung cancer: a multi-centric AERIO analysis of prognostic factorsW Jacot, X Quantin, J M Boher, et al.
Seminars in Oncology|October 1, 1994
A three-arm trial of vinorelbine (Navelbine) plus cisplatin, vindesine plus cisplatin, and single-agent vinorelbine in the treatment of non-small cell lung cancer: an expanded analysisT Le Chevalier, J L Pujol, J Y Douillard, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 1994
Randomized study of vinorelbine and cisplatin versus vindesine and cisplatin versus vinorelbine alone in advanced non-small-cell lung cancer: results of a European multicenter trial including 612 patientsT Le Chevalier, D Brisgand, J Y Douillard, et al.
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|November 1, 1989
Substance P activation of bronchoalveolar macrophages from asthmatic patients and normal subjectsJ L Pujol, J Bousquet, J Grenier, et al.
Pageof 16